Trustan 20 Mg. Trustan 40 Mg 20 mg. 40 mg Gastric resistant tablets
PDF Leaflet Revision Date: 18 February 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of gastro-oesophageal reflux disease and prevention of gastric ulcers.
Dosage (summary)
40 mg once daily for erosive reflux; 20 mg once daily for maintenance.
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Caution in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Clopidogrel
- Warfarin
- Digoxin
Contraindications
- Hypersensitivity to esomeprazole
- Concomitant use with atazanavir or nelfinavir
Common side effects
- Headache
- Abdominal pain
- Diarrhoea
- Nausea
Counselling Points
- Take whole with liquid; do not chew or crush
- Monitor for signs of renal issues
- Report any severe gastrointestinal symptoms
Serious warnings
- Risk of tubulointerstitial nephritis
- Increased risk of gastrointestinal infections
- Hypomagnesaemia
Important Disclaimer
The Trustan 20 Mg. Trustan 40 Mg 20 mg. 40 mg Gastric resistant tablets professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
